SUMMARY Needle biopsies from vastus lateralis in untreated hypothyroid patients with muscle weakness confirmed by quadriceps force measurements (n = 11) were repeated when the patients had taken L-thyroxine for a mean period of 9-2 months (range 5.3-13-3 months, n =8) and had been continuously biochemically euthyroid for a mean period of 4-9 months (range 2-11 months). Biopsies were analysed biochemically for mitochondrial function. On The aim of our study was to characterise abnormalities in histochemistry, electronmicroscopy, mitochondrial function and to measure mean fibre area and percentages of both type I and type II fibres in untreated hypothyroidism and to observe the effects of treatment on these abnormalities.
SUMMARY Needle biopsies from vastus lateralis in untreated hypothyroid patients with muscle weakness confirmed by quadriceps force measurements (n = 11) were repeated when the patients had taken L-thyroxine for a mean period of 9-2 months (range 5.3-13-3 months, n =8) and had been continuously biochemically euthyroid for a mean period of 4-9 months (range 2-11 months). Biopsies were analysed biochemically for mitochondrial function. On light microscopy, histochemical examination, mean fibre areas and fibre percentages of type I and type II fibres were determined. Electronmicroscopy was also performed. Abnormalities on light microscopy occurred in eight patients of which type II fibre atrophy was the commonest and of the remainder two patients showed a myopathic electromyogram (EMG) and a raised plasma creatine kinase activity and one ultrastructural change on biopsy. After treatment resolution of pathological changes was often slow and half the patients had persistent abnormalities when rebiopsied.
The type I mean fibre area was significantly increased in the eight hypothyroid females (p < 0-05) and type II mean fibre areas tended to be low and in females this was significant (p < 0-05). After treatment the type I mean fibre area was significantly reduced (p = 0.05). The type II mean fibre area also tended to fall but this was not significant (p > 0-05). No change in the fibre percentages occurred.
A myopathic EMG, a raised plasma creatine kinase activity, ultrastructural changes and low mitochondrial enzyme activities on needle biopsy were other common findings and their significance is discussed. Results Table 1 shows that a raised plasma CK activity and a myopathic EMG were common findings. In patients 1 and 3 the plasma creatine kinase was high at activities usually associated with muscular dystrophy. In every instance it fell to normal with treatment. Both patients 4 and 11 had a myopathic EMG, sampling the quadriceps muscle, despite a normal needle biopsy on light microscopy. Table 2 outlines the histological findings and mean fibre areas of type I and type II fibres in our hypothyroid patients compared to normal subjects. Abnormalities on biopsy were common and persisted in a substantial proportion of the same patients when euthyroid, though considerable improvement had often occurred. Fig. 1 shows the characteristic type II fibre atrophy. Fig. 2 shows fibre enlargement (identified on an ATPase stain as type I fibres) with progressive reduction in the size of these fibres on serial biopsies, and increased internal nuclei. Many abnormalities still persisted after patient 1 had been euthyroid for nine months.
VASTUS LATERALIS NEEDLE BIOPSY FINDINGS

Light microscopy
The Fibre percentages and mitochondrial enzyme activities Table 3 shows that no change occurred in the fibre percentages with treatment and that these were in the middle of the normal range. The mitochondrial enzyme activities tended to be at the lower end of Discussion the normal range for all the enzymes measured in the hypothyroid patients and no significant change Our study showed that weak patients with occurred in the levels of the cytochrome oxidase hypothyroidism had abnormalities on needle biopsy enzyme activities with treatment.
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group.bmj.com on October 20, 2017 -Published by http://jcp.bmj.com/ Downloaded from hypothyroid patients however are weak. Indeed, Wiles et al, using the same force measuring equipment, found only two of their eight hypothyroid patients were weak. During submaximal isometric quadriceps contractions held to fatigue, their hypothyroid patients sustained comparable levels of force for longer than normal subjects at reduced energy cost.8 Our patients had advanced hypothyroidism both clinically and biochemically and associated high plasma CK activities. The only patient with both a normal EMG and a needle biopsy in this series also had the highest serum thyroxine (63 nmolI1) the lowest serum TSH (15 IU/l) and also a normal plasma CK (54 IU/l). On symptomatic enquiry our patients had had prolonged hypothyroidism at presentation and thus both severity and chronicity might explain the high incidence of myopathy in our series.
Type II fibre atrophy was common in our patients in agreement with others38 and was confirmed by mean fibre area measurements. The technique used9 was particularly valuable for determining the extent of type II fibre atrophy. Our finding of large type I mean fibre areas in the untreated female hypothyroid patients as opposed to normal type I fibre diameters in McKeran's series3 might possibly be explained by the greater precision of the present technique. Wiles et al did however find large type I fibre diameters in three female hypothyroid patients.8 The reduction of type I fibre area with treatment has not previously been noted and occurred in association with a slight reduction in type II mean fibre area though the latter was not significant. In two of our patients biopsies were performed on treatment but before the patient was euthyroid and no reduction in type I mean fibre area had occurred. This suggests that even this early pathological change is slow compared to the rapid improvement in the raised plasma creatine kinase, low urinary 3 methylhistidine excretion and prolonged ankle jerk relaxation time in treated hypothyroidism.23 One possible explanation for the type I mean fibre area enlargement in hypothyroidism is a compensatory mechanism on the part of skeletal muscle to the type II fibre atrophy. Certainly in the two patients with the most severe fibre atrophy (patients 1 and 2) the type I mean fibre areas were the largest. However in other conditions associated with type II fibre atrophy such as steroid myopathy '4 The frequency of abnormalities on electronmicroscopy of vastus lateralis in our hypothyroid patients was impressive, including patient 4 whose biopsy on light microscopy was normal. Honeycombing of mitochondria, the presence of vacuolation, a dense matrix and lipid inclusions in mitochondria have all been described.67 '9 In the present series abnormal mitochondria were often seen in association with glycogen inclusions in focal or widespread areas of myofilament loss. Others have related the presence of glycogen inclusions in muscle fibres to the clinical severity of the myxoedema.5 It has been attributed to diminished enzyme activity in glycogen metabolism in hypothyroidism.6 Low fasting blood glucose concentrations in the early morning in hypothyroid myopathy and the failure of lactate to rise after forearm ischaemia supports this idea.20 These inclusions are not always rapidly lost when treatment is started. '6 Mitochondrial enzyme activities were at the lower end of the normal range with normal ratios of cytochrome oxidase to succinate cytochrome reductase implying functionally normal but reduced numbers of mitochondria. These low activities occurred despite an increase in type I fibre area, and as type I fibres are usually rich in oxidative enzymes, it is possible this reduction in activity was due to hypothyroidism directly or indirectly by inactivity. Although no change in the activities occurred with treatment, a marked reduction in type I area was observed and so in proportion to the area of type I fibres present, activities actually rose. Before rapid erroneous interpretations are made however, more information about the influence of activity and inactivity on these mitochondrial enzymes is needed and this is at present being studied. The technique does appear a promising one for correlating structure, function and metabolism at the cellular level and possibly also the effects of treatment.
Although it is well known that the plasma CK may be raised in hypothyroidism21 striking increases as in patients 1 and 3 are not so well known22 and may suggest coexisting muscular dystrophy to the unwary, particularly in patient 1 with calf hypertrophy and proximal weakness. McKeran comments on the biochemical severity of hypothyroidism correlating with the frequency of pathological changes in muscle. '6 In our series all but patient 4 with a raised plasma CK had associated structural changes. Our patients had had long-standing symptomatic evidence of hypothyroidism and chronicity as well as biochemical severity might have been equally important in the genesis of these changes. In every patient the plasma CK activity fell rapidly with treatment to normal before any increase in strength or structural change occurred23 and others have commented on the mechanisms including changes in capillary permeability. 24 In 
